Gastrointestinal effects GLP-1 medications commonly cause nausea, bloating, constipation, and diarrhea
Yet despite their widespread clinical use, key questions remain about how these drugs reshape patient behavior around food, their metabolism over time, and why individual responses to the drug vary so widely
Past pancreatitis may also be an obstacle
In addition, studies have shown that use of GLP-1RA has significant reduction in MI, CV mortality, and/or MACE in patients with a history of MI [12, 76], with our data demonstrating reduction in unstable angina and coronary revascularization risk in the secondary preventative cohort
Never use the same syringe for both tasks
Injectables built the category, but pills can expand it